OPIANT PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2010 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2022 was 5.14M shares, a 15.3% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 5.92M shares, a 39.3% increase from 2020.
  • Opiant Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 4.25M shares, a 20.5% decline from 2019.
  • Opiant Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2019 was 5.34M shares, a 79% increase from 2018.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 5.14M -927K -15.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 5.09M -340K -6.27% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 5.02M +732K +17.1% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 5.92M Oct 1, 2021 Dec 31, 2021 10-K 2022-03-15
Q3 2021 6.07M +1.22M +25.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 5.43M +1.17M +27.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 4.28M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 4.85M -575K -10.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 4.26M -870K -17% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q3 2019 5.42M +2.55M +88.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 5.13M +2.45M +91.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q3 2018 2.87M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 2.68M +535K +24.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q2 2017 2.14M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 2.01M -721K -26.4% Feb 1, 2017 Apr 30, 2017 10-Q 2017-06-14
Q4 2016 2.17M -435K -16.7% Nov 1, 2016 Jan 31, 2017 10-Q 2017-03-15
Q1 2016 2.73M +905K +49.4% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-14
Q4 2015 2.61M +799K +44.2% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-15
Q1 2015 1.83M Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 1.81M Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-15
Q3 2012 167M +60.6M +56.7% Aug 1, 2012 Oct 31, 2012 10-Q 2012-12-20
Q1 2012 128M +53.4M +72.1% Feb 1, 2012 Apr 30, 2012 10-Q 2012-06-14
Q4 2011 117M +49.1M +72.4% Nov 1, 2011 Jan 31, 2012 10-Q 2012-03-16
Q3 2011 107M +45.3M +73.6% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-20
Q1 2011 74.1M Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 67.8M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q3 2010 61.6M Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.